Pneumococcal Interaction with Human Dendritic Cells: Phagocytosis, Survival, and Induced Adaptive Immune Response Are Manipulated by PavA

被引:42
作者
Noske, Nadia [1 ,2 ,3 ]
Kaemmerer, Ulrike [4 ]
Rohde, Manfred [5 ]
Hammerschmidt, Sven [1 ,2 ,3 ]
机构
[1] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany
[2] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany
[3] Univ Wurzburg, Res Ctr Infect Dis, Wurzburg, Germany
[4] Univ Wurzburg, Dept Obstet & Gynecol, Wurzburg, Germany
[5] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Braunschweig, Germany
关键词
STREPTOCOCCUS-PNEUMONIAE; VIRULENCE FACTORS; CAPSULAR POLYSACCHARIDE; MARGINAL ZONE; DC-SIGN; COLONIZATION; ADHERENCE; PROTEIN; RECOGNITION; DISEASE;
D O I
10.4049/jimmunol.0804383
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) ingest and process bacteria for presenting their Ags to T cells. PavA (pneumococcal adherence and virulence factor A) is a key virulence determinant of pneumococci under in vivo conditions and was shown to modulate adherence of pneumococci to a variety of nonprofessional phagocytic host cells. Here, we demonstrated the role of PavA for the interaction of human DCs with live pneumococci and analyzed the induced host cell responses upon ingestion of viable pneumococci. Expression of PavA protected pneumococci against recognition and actin cytoskeleton-dependent phagocytosis by DCs compared with iso-genic pavA mutants. A major proportion of internalized pneumococci were found in membrane-bound phagosomes. Pneumococcal phagocytosis promotes maturation of DCs, and both wild-type pneumococci and PavA-deficient pneumococci triggered production of proinflammatory cytokines such as IL-1 beta, IL-6, IL-8, IL-12, and TNF-alpha and antiinflammatory IL-10. However, cytokine production was delayed and reduced when DCs encounter pneumococci lacking PavA, which also results in a less efficient activation of the adaptive immune response. Strikingly, purified PavA reassociates to pneumococci but not DCs and reduced phagocytosis of the pavA mutant to levels similar to those of wild-type pneumococci. Additionally, pavA mutants covered with exogenously provided PavA protein induced a DC cytokine profile similar to wild-type pneumococci. In conclusion, these results suggest that PavA is key factor for live pneumococci to escape phagocytosis and to induce optimal cytokine productions by DCs and adaptive immune responses as well. The Journal of Immunology, 2009, 183: 1952-1963.
引用
收藏
页码:1952 / 1963
页数:12
相关论文
共 53 条
[1]   Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae [J].
Abeyta, M ;
Hardy, GG ;
Yother, J .
INFECTION AND IMMUNITY, 2003, 71 (01) :218-225
[2]   Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice [J].
Albiger, B ;
Sandgren, A ;
Katsuragi, H ;
Meyer-Hoffert, U ;
Beiter, K ;
Wartha, F ;
Hornef, M ;
Normark, S ;
Normark, BH .
CELLULAR MICROBIOLOGY, 2005, 7 (11) :1603-1615
[3]   STREPTOCOCCUS-PNEUMONIAE - VIRULENCE FACTORS, PATHOGENESIS, AND VACCINES [J].
ALONSODEVELASCO, E ;
VERHEUL, AFM ;
VERHOEF, J ;
SNIPPE, H .
MICROBIOLOGICAL REVIEWS, 1995, 59 (04) :591-&
[4]   The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles [J].
Arredouani, M ;
Yang, ZP ;
Ning, YY ;
Qin, GZ ;
Soininen, R ;
Tryggvason, K ;
Kobzik, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (02) :267-272
[5]  
AUSTRIAN R, 1981, REV INFECT DIS, V3, pS1
[6]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[7]   Versatility of pneumococcal surface proteins [J].
Bergmann, S ;
Hammerschmidt, S .
MICROBIOLOGY-SGM, 2006, 152 :295-303
[8]   Streptococcus pneumoniae colonisation:: the key to pneumococcal disease [J].
Bogaert, D ;
de Groot, R ;
Hermans, PWM .
LANCET INFECTIOUS DISEASES, 2004, 4 (03) :144-154
[9]   Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[10]   Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management [J].
Cartwright, K .
EUROPEAN JOURNAL OF PEDIATRICS, 2002, 161 (04) :188-195